Sign In
Buy RMTI
$7.19
+0.0900 (+1.27%)
At Close: Jul 31, 2026
Rockwell Medical (RMTI) is a Great Momentum Stock: Should You Buy?
01:00pm, Monday, 09'th Sep 2024
Does Rockwell Medical (RMTI) have what it takes to be a top stock pick for momentum investors? Let's find out.
Why Fast-paced Mover Rockwell Medical (RMTI) Is a Great Choice for Value Investors
09:51am, Monday, 09'th Sep 2024
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Rockwell Medical (RMTI) could be a great choice. It is one of the several stocks tha
Rockwell Medical, Inc. (RMTI) Hit a 52 Week High, Can the Run Continue?
10:16am, Wednesday, 04'th Sep 2024
Rockwell Medical (RMTI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Rockwell Medical, Inc. (RMTI) Hits Fresh High: Is There Still Room to Run?
10:15am, Monday, 19'th Aug 2024
Rockwell Medical (RMTI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Fast-paced Momentum Stock Rockwell Medical (RMTI) Is Still Trading at a Bargain
09:51am, Thursday, 15'th Aug 2024
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Rockwell Medical (RMTI) could be a great choice. It is one of the several stocks tha
Rockwell Medical, Inc. (RMTI) Q2 2024 Earnings Call Transcript
01:33pm, Thursday, 08'th Aug 2024
Rockwell Medical, Inc. (RMTI) Q2 2024 Earnings Call Transcript
Rockwell Medical (RMTI) Tops Q2 Earnings and Revenue Estimates
08:16am, Thursday, 08'th Aug 2024
Rockwell Medical (RMTI) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.04 per share. This compares to loss of $0.18 per share a year ago.
Rockwell Medical Reports Profitability on a Cash Flow and Adjusted EBITDA Basis in the Second Quarter of 2024
06:00am, Thursday, 08'th Aug 2024
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical today announced financial and operational results for the three and six months ended June 30, 2024.
Rockwell Medical Launches Convenience Pack to Support Home Hemodialysis and Acute Dialysis Facilities
06:00am, Wednesday, 07'th Aug 2024
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical's Convenience Pack offers a number of advantages for home hemodialysis patients and acute care dialysis facilities.
Rockwell Medical Looks Like A Speculative Buy As It Approaches Profitability
08:00am, Sunday, 21'st Jul 2024
Rockwell is a microcap manufacturer of hemodialysis concentrates for kidney failure patients, trading at under 1x full-year 2023 revenue. The company has a significant market opportunity with the grow
Rockwell Medical to Release Second Quarter 2024 Results on Thursday, August 8, 2024
06:00am, Thursday, 11'th Jul 2024
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its financial and operational results for the second quarter ended June 30, 2024 on Thursday, August 8, 20
3 Penny Stocks With 735% Average Upside, According to Wall Street
10:47am, Tuesday, 09'th Jul 2024
With the third quarter in full swing, the bulls have not lost their grip on equities.
Rockwell Medical Promotes Tim Chole to Chief Commercial Officer
06:00am, Thursday, 30'th May 2024
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Mr. Chole has played a key role in helping Rockwell Medical increase its market share and broaden its product portfolio.
Rockwell Medical, Inc. (NASDAQ:RMTI) Expected to Post Q2 2024 Earnings of ($0.04) Per Share
01:06am, Monday, 20'th May 2024
Rockwell Medical, Inc. (NASDAQ:RMTI – Free Report) – Research analysts at HC Wainwright lowered their Q2 2024 EPS estimates for shares of Rockwell Medical in a report released on Thursday,
Rockwell Medical, Inc. (RMTI) Q1 2024 Earnings Call Transcript
09:28am, Tuesday, 14'th May 2024
Rockwell Medical, Inc. (NASDAQ:RMTI ) Q1 2024 Earnings Conference Call May 14, 2024 8:00 AM ET Company Participants Heather Hunter - Senior Vice President, Chief Corporate Affairs Officer Mark Strobec
